Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

To prospectively evaluate the prevalence of hepatitis B virus (HBV) positivity and study the evolution of HBV profile during cancer chemotherapy, serum HBV markers and liver biochemistry were determined in 1008 of 1402 (72%) cancer patients admitted in our Unit and in all 920 (91%) who received chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexopoulos, C G, Vaslamatzis, M, Hatzidimitriou, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374347/
https://www.ncbi.nlm.nih.gov/pubmed/10487614
http://dx.doi.org/10.1038/sj.bjc.6690652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374347/
https://www.ncbi.nlm.nih.gov/pubmed/10487614
http://dx.doi.org/10.1038/sj.bjc.6690652

Ejemplares similares